Editorial Criteria
Submissions to Bio-101 must adhere to the following editorial criteria:
  • The protocol falls within the remit of our Aims and Scope. Please refer to our Submission Procedure for further details.

  • The protocol is structured in an appropriate format that clearly describes the experimental procedure, including separate sections for the abstract, materials and reagents, equipment, procedure, data analysis, recipes, acknowledgments, and references (see Protocol Preparation Guidelines for our recommended format).

  • There is demonstrable evidence that the submitted protocol works. Authors are encouraged to provide a citation of a publication or preprint where they successfully used the protocol described. If this is not provided, the protocol will be labeled as such until it is successfully executed by one of our readers.

  • The protocol contains sufficient detail to enable other researchers to effectively reproduce the steps described.

  • The protocol is clearly written in formal English.

  • Figures, videos, tables, animations and other supporting media are of acceptable publication quality, relevant to the protocol, and clearly described using appropriate legends.

  • The protocol adheres to all relevant standards (e.g., NIH for NIH-funded researchers) for experimentation and research integrity.

  • The authors sign our License to Publish agreement.

Sharing of Resources
We expect our authors to share materials from their protocols upon request. Relevant materials include strains and isolates, vectors, gene constructs, seeds, cuttings, genotypes, ecotypes, tissue samples, and other similar materials. Authors must also submit data and materials from their protocol to appropriate public repositories wherever applicable.
Appealing an Editorial Decision
Authors can appeal an editorial decision by emailing the Executive Editor that handled their submission with "Appeal of Editorial Decision" in the subject line of the email. The Executive Editor will guide the author on how to prepare a detailed appeal letter, which should state precisely why the author is appealing a decision. At Bio-101, the formal appeal letter will be discussed by at least 5 members of the editorial board. We aim to make a decision within three weeks of receiving the formal appeal letter.
Corrections and Retractions
Authors are requested to notify the Executive Editor that handled their submission about any errors identified in their published protocol as soon as possible after they become aware of the error. The errors will be corrected and the protocol will be updated clearly indicating that it is a corrected version. A significant error can also lead to retraction of a protocol. Protocols may be retracted by authors, sponsors, or editors due to irreproducible data or gross errors. A retraction notice will appear in the database including the title of the original protocol with an explanation of why it was retracted.
Bio-101 is a protocol database and may therefore contain protocols that have previously been described in detail elsewhere. However, Bio-101 authors cannot plagiarize prior work. Plagiarism consists of two forms: a) self-plagiarism, in which authors reuse significant parts of their own previously published work without appropriate references; and b) copying, in which authors present someone else's published work as their own. Significant plagiarism will be determined by the Associate Editor assigned to the manuscript, and if found to violate the acceptable standard of using other pieces of work with appropriate attribution, will not be accepted into the database at Bio-101. Minor incidents of plagiarism without intent, for example using 1 or 2 lines from their own previous Materials and Methods section of a paper, will not be considered a violation of plagiarism ethics. Bio-101 supports initiatives such as CrossCheck.
At Bio-101, we are a member of the Committee on Publication Ethics (COPE) and fully support guidelines for publication ethics established by the Council of Science Editors (CSE), the International Committee of Medical Journal Editors (ICMJE) and COPE. These include but are not limited to: standards for treatment of research subjects; falsification and fabrication of data; and piracy and plagiarism. For animal research, we recommend following the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. All protocols that have used human and/or animal subjects must mention the specific ethics committee that approved the described experiment. Protocols including human subjects should also indicate that informed consent was obtained from all subjects. We further expect authors to meet the ICMJE criteria for authorship and to accurately report any conflicts of interest.
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.